BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors
A phase 1/2 trial of CAR-GPC3 T Cells in hepatocellular carcinoma, non-small-cell lung cancer, merkel cell carcinoma and sarcomas, run by Sotio Biotech Inc., active and no longer recruiting.
Overview
BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors is a phase 1/2 interventional study registered as NCT05120271 by Sotio Biotech Inc., with 7 participants enrolled, started 2022-10-26 and due to reach its primary completion in 2025-10-24. Interventions recorded: CAR-GPC3 T Cells.
Similar pages
not linked directly; found by shared links- TrialIntratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS
Shares Sarcomas (soft tissue, bone, GIST), Non-small-cell lung cancer and the tag pipeline.
- TrialA Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
Shares Hepatocellular carcinoma, Non-small-cell lung cancer and the tag pipeline.
- TrialA Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
Shares Sarcomas (soft tissue, bone, GIST), Non-small-cell lung cancer and the tag pipeline.
- TrialStudy of GV20-0251 in Participants With Solid Tumor Malignancies
Shares Hepatocellular carcinoma, Non-small-cell lung cancer and the tag pipeline.
- TrialSL-28 for Advanced Solid Tumours
Shares Hepatocellular carcinoma, Non-small-cell lung cancer and the tag pipeline.
- TrialA Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21)
Shares Merkel cell carcinoma and the tag pipeline.
- TrialClinical Study of VG161 in the Treatment of Advanced Bone and Soft Tissue Sarcoma
Shares Sarcomas (soft tissue, bone, GIST) and the tag pipeline.
- TrialA Study of RNK08954 in Subjects With Advanced Solid Tumors With KRAS ((Kirsten Rat Sarcoma) G12D Mutation
Shares Sarcomas (soft tissue, bone, GIST) and the tag pipeline.